MOLECULAR ALTERATIONS IN IDH-MUTANT ASTROCYTOMA: A MULTI-INSTITUTIONAL RETROSPECTIVE STUDY

被引：0

作者：

Lam, Keng ^{[1
]}

Ozkizilkaya, Hanim ^{[2
]}

Milton, Denai ^{[3
]}

Dono, Antonio ^{[4
]}

Kumar, Vinodh ^{[5
]}

Johnson, Jason ^{[6
]}

Esquenazi, Yoshua ^{[4
]}

Patel, Chirag ^{[1
]}

Ballester, Leomar ^{[7
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX USA

[2] Univ Southern Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA

[4] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX USA

[5] Univ Texas MD Anderson Canc, Dept Neuroradiol, Houston, TX USA

[6] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA

[7] Univ Texas MD Anderson Canc, Dept Anat Pathol, Houston, TX USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae165.0715

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PATH-16

引用

页数：1

共 50 条

[21] A case of anaplastic astrocytoma with appearance of IDH-mutant astrocytic cells at recurrence
Sakamoto, Noriaki
Ishikawa, Eiichi
Sakakura, Kazuki
Ishikawa, Takaaki
Sakashita, Shingo
Noguchi, Masayuki
Matsumura, Akira
BRAIN PATHOLOGY, 2019, 29 : 148 - 148
[22] A multicenter retrospective study of the duration of adjuvant temozolomide in IDH-mutant gliomas
Densmore, Isabella
Lanman, Tyler Ashford
McGranahan, Tresa
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[23] Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma
Masui, Kenta
Onizuka, Hiromi
Muragaki, Yoshihiro
Kawamata, Takakazu
Kurata, Atsushi
Komori, Takashi
BRAIN TUMOR PATHOLOGY, 2024, 41 (02) : 92 - 95
[24] Integrated molecular characterization of IDH-mutant glioblastomas
Korshunov, A.
Casalini, B.
Chavez, L.
Hielscher, T.
Sill, M.
Ryzhova, M.
Sharma, T.
Schrimpf, D.
Stichel, D.
Capper, D.
Reuss, D. E.
Sturm, D.
Absalyamova, O.
Golanov, A.
Lambo, S.
Bewerunge-Hudler, M.
Lichter, P.
Herold-Mende, C.
Wick, W.
Pfister, S. M.
Kool, M.
Jones, D. T. W.
von Deimling, A.
Sahm, F.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2019, 45 (02) : 108 - 118
[25] Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocytoma Comment
Sasaki, Hikaru
LANCET ONCOLOGY, 2021, 22 (06): : 743 - 744
[26] SECONDARY GLIOBLASTOMA, IDH-WILDTYPE ARISING IN DIFFUSE ASTROCYTOMA, IDH-MUTANT: A CASE REPORT
Lee, Kyu Sang
Choe, Gheeyoung
NEURO-ONCOLOGY, 2019, 21 : 99 - 99
[27] IDH-wildtype secondary glioblastoma arising in IDH-mutant diffuse astrocytoma: a case report
Yoon, Byul-Hee
Park, Ju Sang
Kang, Seongmin
Kwon, Nak-Jung
Lee, Kyu Sang
Kim, Chae-Yong
Choe, Gheeyoung
BRITISH JOURNAL OF NEUROSURGERY, 2023, 37 (05) : 1233 - 1236
[28] A MULTI-INSTITUTIONAL COMPARATIVE ANALYSIS OF THE CLINICAL, GENOMIC, AND SURVIVAL CHARACTERISTICS OF PEDIATRIC, YOUNG ADULT AND OLDER ADULT PATIENTS WITH IDH-MUTANT GLIOMA
Lim-Fat, Mary Jane
Vogelzang, Jayne
Woodward, Eleanor
McGovern, Alana
Ma, Clement
Al-sayegh, Hasan
Alexandrescu, Sanda
Margol, Ashley
Cotter, Jennifer
Cole, Kristina
Li, Marilyn
Owens, Emily
Smith, Amy
Goldman, Stewart
Kaneva, Kristiyana
Burton, Emily
Nazemi, Kellie
Wright, Karen
Wen, Patrick
Warren, Katherine
Touat, Mehdi
Reardon, David
Bi, Wenya Linda
Ligon, Keith
Yeo, Kee Kiat
NEURO-ONCOLOGY, 2020, 22 : 80 - 81
[29] IDH-Mutant Gliomas Differ in Distribution of Mitochondrial Genomic Alterations
Ozduman, Koray
Yuksel, Sirin
Akyerli, Cemaliye
Bilguvar, Kaya
Ersen-Danyeli, Ayca
Yilmaz, Engin
Pamir, M. Necmettin
JOURNAL OF NEUROSURGERY, 2020, 132 (04) : 84 - 84
[30] Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p19q-codeleted in a patient with CCDC26 polymorphism
Vaubel, Rachael
Kollmeyer, Thomas
Caron, Alissa
Fritcher, Emily Barr
Voss, Jesse
Liang, Haohai
Jenkins, Robert
Kipp, Benjamin
Giannini, Caterina
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (06): : 512 - 512

← 1 2 3 4 5 →